Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 7, 2011 INMD, ELN, RNR, LAB, PRCP, CNC Expected To Be Down After Next Earnings Releases
February 7, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, February 8th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and February earnings reports. INTEGRAMED AMERICA INC (NASDAQ:INMD), ELAN CORP PLC -SPONS ADR (NYSE:ELN), RENAISSANCERE HOLDINGS LTD (NYSE:RNR), LABRANCHE & CO INC (NYSE:LAB), PERCEPTRON INC (NASDAQ:PRCP), CENTENE CORP (NYSE:CNC) are all expected to be Down After their earnings are released Tuesday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:
Symbol Company # of Reports Quarter Release Time
INMD INTEGRAMED AMERICA INC February Earnings Q4 Before
ELN ELAN CORP PLC -SPONS ADR 6 Quarter Q4 Before
RNR RENAISSANCERE HOLDINGS LTD 12 Quarter Q4 After
LAB LABRANCHE & CO INC 6 Quarter Q4 Before
PRCP PERCEPTRON INC 6 Quarter Q2 After
CNC CENTENE CORP 6 Quarter Q4 Before
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
INTEGRAMED AMERICA INC (NASDAQ:INMD) - IntegraMed America, Inc., a specialty healthcare services company, manages outpatient centers offering products and services to patients and providers in the fertility and vein care segments of the health industry in the United States. It operates through three divisions: Fertility Centers, Consumer Services, and Vein Clinics. The Fertility Centers division provides business and management services to a network of 14 contracted fertility centers that perform diagnostic tests on women and men to determine the cause of infertility, as well as offer various treatment options, including IVF treatment, frozen embryo transfer, intrauterine insemination, and minimally invasive surgery to correct anatomical reproductive problems. The Consumer Services division offers Attain IVF programs, which are designed to help patients attain their goal of starting a family. It offers these programs directly to fertility patients, including patients of its partner centers and patients of the divisions contracted network of independent medical providers under its affiliate program. As of December 31, 2009, this division maintained a contracted network of 25 independent fertility centers under its affiliate program. The Vein Clinics division provides business and management services to clinics. This division managed a network of 34 clinics in 13 states, which specialize in the treatment of vein disease and other vein disorders. The company was founded in 1985 and is headquartered in Purchase, New York.
ELAN CORP PLC -SPONS ADR (NYSE:ELN) - Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, BioNeurology and Elan Drug Technologies (EDT). The BioNeurology segment engages in the research, development, and commercial activities primarily in the areas of Alzheimers disease, Parkinsons disease, multiple sclerosis (MS), Crohns disease, and severe chronic pain. Its offers Tysabri to treat relapsing forms of MS; Prialt, a non-opioid and intrathecal analgesic for the treatment of severe chronic pain, principally neuropathic pain; Azactam, a monobactam to treat pneumonia, post-surgical infections, and septicemia; and Maxipime, an injectable cephalosporin antibiotic used to treat patients with serious and/or life-threatening infections. This segment in collaboration with Biogen Idec, Inc., develops and markets Tysabri for the treatment for Crohns disease. It also develops beta amyloid immunotherapies for the treatment of Alzheimers disease through collaboration with Wyeth. In addition, this segment develops ELND005, a novel therapeutic agent, which is in Phase II clinical study to treat Alzheimers disease; ELND006, a small molecule gamma secretase inhibitor is in Phase I clinical studies for the treatment of Alzheimers disease; and Beta secretase, a precursor to plaque development in the brain. Further, BioNeurology segment has collaboration agreement with PharmatrophiX to develop small molecule ligands for growth factor receptors relevant to neurological disorders. The EDT segment offers pharmaceutical products using its proprietary drug technologies. It also provides formulation development services and contract manufacturing services that include analytical development, clinical trial manufacturing, scale-up, product registration support, and supply chain management. Elan Corporation sells its products primarily to drug wholesalers. The company was founded in 1969 and is headquartered in Dublin, Ireland.
RENAISSANCERE HOLDINGS LTD (NYSE:RNR) - RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products and services worldwide. The company operates through two segments, Reinsurance and Individual Risk. The Reinsurance segment provides property catastrophe reinsurance products, including catastrophe excess of loss reinsurance and excess of loss retrocessional reinsurance; and specialty reinsurance products, such as catastrophe exposed workers compensation, surety, terrorism, political risk, trade credit, medical malpractice, catastrophe exposed personal lines property, casualty clash, property per risk, catastrophe exposed personal lines property, and other specialty lines of reinsurance. The Individual Risk segment identifies and writes various classes of business, such as multi-peril crop insurance, crop hail, and other named peril agriculture risk management products; commercial property, which principally includes catastrophe-exposed commercial property products; commercial multi-line that consists of commercial property and liability coverage, such as general liability, automobile liability and physical damage, building and contents, and professional liability; and personal lines property, which principally comprises homeowners personal lines property coverage and catastrophe exposed personal lines property coverage. The company offers its products and services through intermediaries. RenaissanceRe Holdings Ltd. was founded in 1993 and is based in Pembroke, Bermuda.
LABRANCHE & CO INC (NYSE:LAB) - LaBranche & Co Inc., through its subsidiaries, operates as a registered broker-dealer. It operates as market-maker in options, futures, and exchange-traded funds (ETF) traded on various exchanges. The company operates in two segments, Market-Making and Institutional Brokerage. The Market-Making segment operates as a market maker in equity, index and ETF options, ETFs, and futures on the NYSE Amex Exchange, the NYSE Arca Exchange, the New York Board of Trade, the Philadelphia Stock Exchange, and the Chicago Board Options Exchange; broker-dealer registered with the United Kingdoms Financial Securities Authority; market maker for ETFs traded on the London Stock Exchange, and the Euroex and Euronext Exchanges; broker-dealer with Hong Kongs Securities and Futures Commission; and market maker for ETFs in Hong Kong, as well as engages in hedging transactions in Asia. The Institutional Brokerage segment provides securities execution, fixed income, and professional trading brokerage services to institutional investors and professional traders; and operates as a market maker in over-the-counter, bulletin board, and pink sheet securities. This segment also engages in agency business that trades high-yield debt for its institutional customers, as well as acts as an agent in transactions related to leveraged loans and commercial loans. The company was founded in 1924 and is based in New York, New York.
PERCEPTRON INC (NASDAQ:PRCP) - Perceptron, Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of information-based measurement and inspection solutions for process improvements primarily for the automotive industry. It provides AutoGauge systems, which are used in the assembly and fabrication plants of auto manufacturers and their suppliers to contain, correct, and control the quality of body structures; and AutoFit systems for use in automotive manufacturing plants to contain, correct, and control the fit of exterior body panels. The company also offers AutoScan systems, which provide a non-contact method of gathering data for the analysis of the surface contour of a part or product, such as automotive closure panels; and AutoGuide systems that calculate the difference between theoretical and actual relationships of a robot and the part being assembled, and send compensation data in six axes to the robot. In addition, Perceptron provides technology products, including ScanWorks, a hardware/software component set that allows customers to add digitizing capabilities to their machines or systems; ToolKit, a software solution for CMM manufacturers, system integrators, and application software developers; and WheelWorks software and sensors for use in automated or manual wheel alignment machines. Further, it develops products and accessories, such as visual inspection devices and optical technology tools for professional tradesmen. Additionally, the company offers value-added services comprising training, field services, launch support services, consulting services, maintenance agreements, repairs, and software tools. It markets its products directly, as well as through manufacturing line builders, system integrators, value added resellers, and original equipment manufacturers. The company operates in the United States, Europe, Canada, Asia, and South America. Perceptron, Inc. was founded in 1981 and is headquartered in Plymouth, Michigan.
CENTENE CORP (NYSE:CNC) - Centene Corporation operates as a multiline healthcare company in the United States. It operates through two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides medicaid and medicaid-related health plan coverage to individuals through government subsidized programs, including medicaid, the state childrens health insurance program, foster care, and medicare special needs plans, as well as aged, blind, or disabled (ABD) program. Its health plans principally provide primary and specialty physician care, inpatient and outpatient hospital care, transportation assistance, emergency and urgent care, vision care, prenatal care, dental care, laboratory and x-ray services, immunizations, prescriptions and over-the-counter drugs, home health and durable medical equipment, behavioral health and substance abuse services, therapies, social work services, and 24-hour nurse advice line. The Specialty Services segment manages behavioral healthcare for members via a contracted network of providers; provides health insurance to individual customers and their families; implements life and health management programs; offers long-term care services to the elderly and people with disabilities; manages vision benefits for members; provides telehealth services; and administers pharmacy benefits and processes pharmacy claims. Centene offers its services through primary and specialty care physicians, hospitals, and ancillary providers. The company was founded in 1984 and is headquartered in St. Louis, Missouri.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
- WOPRAI
- support@woprai.com